latest update:
[TrialBase DB]

trial summary · NCT07907731

Effect of LMWH on Neonatal Outcomes in Isolated Oligohydramnios

Comparison of the Effect of Conventional Method Along With LMWH vs Conventional Method Alone in Improvement of Neonatal Outcomes in Pregnancies Complicated With Isolated Oligohydramnios in 2nd and 3rd Trimester.

Trial record from the TrialBase DB dataset, status RECRUITING, condition Oligohydramnios, sponsored by PAEC General Hospital, Islamabad. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT07907731phase PHASE4enrollment 106start 2026-10-24

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

The pregnant women who meet the study requirements will be included in the study. They will be randomly assigned to receive either the usual treatment or the usual treatment along with an additional medicine. The usual treatment will include fluids given through a vein, rest while lying on the left side, and a low-dose aspirin tablet (75 mg once daily) from the 22nd to the 34th week of pregnancy. Women will also receive 1,000 ml of 5% dextrose fluid daily through a vein, from the time low amniotic fluid is diagnosed until the 36th week of pregnancy. Some women will also receive an additional injection of a blood-thinning medicine called low-molecular-weight heparin (LMWH), at a dose of 40 mg under the skin, from the 22nd to the 36th week of pregnancy. All participants will undergo weekly ultrasound examinations to measure the fluid surrounding the baby and assess blood flow through the umbilical cord. The study will record the number of babies born before 37 weeks of pregnancy, the babies' birth weights, and the number of babies born alive.

Source record: https://clinicaltrials.gov/study/NCT07907731

Facts

registry idNCT07907731
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasePHASE4
study typeINTERVENTIONAL
lead conditionOligohydramnios
sponsorPAEC General Hospital, Islamabad
sponsor classOTHER
enrollment106
start date2026-10-24
primary completion2027-01-25
completion2027-01-30
results postednot reported

Conditions

  • Oligohydramnios
  • Heparin
  • Neonatal Outcomes

Interventions

  • Enoxaparin (LMWH)
  • Dextrose Water

Countries

  • Pakistan

Intervention types: DRUG

Work with this record